TimothyMDempseyMDMPH

Pulmonology • Pittsburgh, PA

Critical Care Medicine, Interstitial Lung Diseases

Pulmonary and Critical Care Physician, Assistant Professor of Medicine

Join to view full profile

Dr. Dempsey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dempsey's full profile

Already have an account?

Office
3459 5th Ave
Pittsburgh, PA 15213
Phone+1 412-692-2210

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 2017 - 2020
University of California Davis HealthResidency, Internal Medicine, 2014 - 2017
Rutgers Robert Wood Johnson Medical SchoolClass of 2014
Dartmouth CollegeMPH, 2009 - 2010

Certifications & Licensure

CA State Medical License 2015 - 2025
MD State Medical License 2024 - 2024
PA State Medical License 2024 - 2024
MN State Medical License 2017 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

24 citations
Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.
Narasimhan J. Venkatachari, Leah A Walker, Oznur Tastan, Thien P Le, Timothy M Dempsey
Virology Journal. 2010-06-07
2 citations
Critical Care Staffing in Pandemics and Disasters: A Consensus Report From a Subcommittee of the Task Force for Mass Critical Care - Systems Strategies to Sustain the ...
Charles L Sprung, Asha V Devereaux, Marya Ghazipura, Lisa D Burry, Tanzib Hossain
Chest. 2023-07-01
8 citations
The Leser-Trélat sign.
Christopher Sardon, Timothy M. Dempsey
Cleveland Clinic Journal of Medicine. 2017-12-01

Press Mentions

Adoption of Newer Antifibrotic Medications for IPF Low in US in Everyday Practice: StudyAugust 13th, 2021
Idiopathic Pulmonary Fibrosis Drugs Increase Longevity, Decrease HospitalizationsJuly 15th, 2019
Ethics of Representing Unrepresented PatientsJuly 3rd, 2019
Join now to see all